Metro Healthcare Indonesia Tbk. vs Putra Mandiri Jembar Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp428 (market cap 14.23T, 346.3K 24h volume), while Putra Mandiri Jembar Tbk. trades at Rp109 (market cap 1.46T, 537.8K 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 9.7× Putra Mandiri Jembar Tbk.'s market cap, and Putra Mandiri Jembar Tbk. is more actively traded (537.8K versus 346.3K). Which is the better fit depends on your goals.
| CARE | PMJS | |
|---|---|---|
Market Cap | 14.23T | 1.46T |
Volume | 346.3K | 537.8K |
Lot | 3.46K | 5.38K |
Turnover | 147.93M | 57.74M |
Average Price | 427.18 | 107.37 |
Value | 147.93M | 57.74M |
Indicative Equilibrium Price | 428 | 109 |
Indicative Equilibrium Volume | 10 | 759 |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Putra Mandiri Jembar Tbk (the Company) was domiciled in Jakarta, established under the Deed No. 52 dated 18 July 2003 by notary Arikanti Natakusumah, S.H. PT Pahalamas Sejahtera is the parent entity and ultimate holding of the Company.
Read more on PMJS →